Main adverse effects and contraindications for approved anti-obesity medications
Medication . | Adverse effects . | Contraindications . |
---|---|---|
Orlistat |
| Chronic malabsorption syndrome; cholestasis; pregnancy |
Naltrexone/bupropion |
| Chronic opioid use; acute opioid withdrawal; uncontrolled hypertension; seizure disorder; bulimia or anorexia nervosa; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiseizure drugs; concomitant use of monoamine oxidase inhibitors; pregnancy |
Liraglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Semaglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Tirzepatide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, known serious hypersensitivity to tirzepatide or any of the excipients |
Setmelanotide |
| Pregnancy |
Medication . | Adverse effects . | Contraindications . |
---|---|---|
Orlistat |
| Chronic malabsorption syndrome; cholestasis; pregnancy |
Naltrexone/bupropion |
| Chronic opioid use; acute opioid withdrawal; uncontrolled hypertension; seizure disorder; bulimia or anorexia nervosa; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiseizure drugs; concomitant use of monoamine oxidase inhibitors; pregnancy |
Liraglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Semaglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Tirzepatide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, known serious hypersensitivity to tirzepatide or any of the excipients |
Setmelanotide |
| Pregnancy |
Main adverse effects and contraindications for approved anti-obesity medications
Medication . | Adverse effects . | Contraindications . |
---|---|---|
Orlistat |
| Chronic malabsorption syndrome; cholestasis; pregnancy |
Naltrexone/bupropion |
| Chronic opioid use; acute opioid withdrawal; uncontrolled hypertension; seizure disorder; bulimia or anorexia nervosa; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiseizure drugs; concomitant use of monoamine oxidase inhibitors; pregnancy |
Liraglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Semaglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Tirzepatide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, known serious hypersensitivity to tirzepatide or any of the excipients |
Setmelanotide |
| Pregnancy |
Medication . | Adverse effects . | Contraindications . |
---|---|---|
Orlistat |
| Chronic malabsorption syndrome; cholestasis; pregnancy |
Naltrexone/bupropion |
| Chronic opioid use; acute opioid withdrawal; uncontrolled hypertension; seizure disorder; bulimia or anorexia nervosa; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiseizure drugs; concomitant use of monoamine oxidase inhibitors; pregnancy |
Liraglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Semaglutide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy |
Tirzepatide |
| Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, known serious hypersensitivity to tirzepatide or any of the excipients |
Setmelanotide |
| Pregnancy |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.